Voyager Therapeutics Inc (VYGR)
EBITDA Margin
-301.17%
TTM · Period ending:
VYGR EBITDA Margin
Latest reported-301.17%period ending
Latest reported-301.17%period ending
VYGR TTM EBITDA Margin (-617.16% → -301.17%)
TTM ebitda margin
High-resolution chart · PNG
VYGR ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -301.1724% | |
| -308.374% | |
| -286.1173% | |
| -389.7081% | |
| -241.9751% | |
| -118.6654% | |
| -74.5066% | |
| 19.439% | |
| 10.3833% | |
| 2.1757% | |
| 55.4114% | |
| 36.115% | |
| 51.8035% | |
| 54.5955% | |
| -98.2765% | |
| -13.5987% | |
| -169.6653% | |
| -201.2068% | |
| -185.3072% | |
| -629.2436% | |
| 7.2574% | |
| 19.1004% | |
| 18.2326% | |
| 20.7503% | |
| -61.8377% | |
| -35.7016% | |
| -44.9751% | |
| -75.8128% | |
| -107.2148% | |
| -810.4767% | |
| -1,157.5797% | |
| -653.6885% | |
| -731.1172% | |
| -766.7603% | |
| -693.3985% | |
| -1,171.1104% | |
| -713.801% | |
| -465.8191% | |
| -286.1181% | |
| -204.1322% | |
| -151.6066% | |
| -113.7839% | |
| -113.3841% | |
| -135.2182% | |
| -221.1394% | |
| -617.1584% |